Literature DB >> 22223788

Cancer research. Cancer prevention with a diabetes pill?

Gary Taubes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22223788     DOI： 10.1126/science.335.6064.29

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  29 in total

Review 1.  The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.

Authors:  Vladimir N Anisimov; Andrzej Bartke
Journal:  Crit Rev Oncol Hematol       Date:  2013-02-21       Impact factor: 6.312

2.  Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs.

Authors:  Richard C Miller; Jeffrey S Murley; David J Grdina
Journal:  Radiat Res       Date:  2014-04-22       Impact factor: 2.841

3.  Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres.

Authors:  Junseong Park; Jin-Kyoung Shim; Joon Hee Kang; Junjeong Choi; Jong Hee Chang; Soo-Youl Kim; Seok-Gu Kang
Journal:  Neuro Oncol       Date:  2018-06-18       Impact factor: 12.300

Review 4.  The effect of environmental chemicals on the tumor microenvironment.

Authors:  Stephanie C Casey; Monica Vaccari; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Mary Helen Barcellos-Hoff; Dustin G Brown; Marion Chapellier; Joseph Christopher; Colleen S Curran; Stefano Forte; Roslida A Hamid; Petr Heneberg; Daniel C Koch; P K Krishnakumar; Ezio Laconi; Veronique Maguer-Satta; Fabio Marongiu; Lorenzo Memeo; Chiara Mondello; Jayadev Raju; Jesse Roman; Rabindra Roy; Elizabeth P Ryan; Sandra Ryeom; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Laura Soucek; Louis Vermeulen; Jonathan R Whitfield; Jordan Woodrick; Annamaria Colacci; William H Bisson; Dean W Felsher
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 5.  Do metformin a real anticarcinogen? A critical reappraisal of experimental data.

Authors:  Vladimir N Anisimov
Journal:  Ann Transl Med       Date:  2014-06

Review 6.  Glycolytic genes in cancer cells are more than glucose metabolic regulators.

Authors:  Zhe-Yu Hu; Lanbo Xiao; Ann M Bode; Zigang Dong; Ya Cao
Journal:  J Mol Med (Berl)       Date:  2014-06-08       Impact factor: 4.599

Review 7.  Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.

Authors:  Avijit Majumdar; Steven A Curley; Xifeng Wu; Powel Brown; Jessica P Hwang; Kirti Shetty; Zhi-Xing Yao; Aiwu Ruth He; Shulin Li; Lior Katz; Patrizia Farci; Lopa Mishra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 46.802

8.  Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway.

Authors:  Sandeep C Chaudhary; Deepali Kurundkar; Craig A Elmets; Levy Kopelovich; Mohammad Athar
Journal:  Photochem Photobiol       Date:  2012-06-01       Impact factor: 3.421

9.  Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.

Authors:  Qing-Shuo Zhang; Weiliang Tang; Matthew Deater; Ngoc Phan; Andrea N Marcogliese; Hui Li; Muhsen Al-Dhalimy; Angela Major; Susan Olson; Raymond J Monnat; Markus Grompe
Journal:  Blood       Date:  2016-10-18       Impact factor: 22.113

10.  LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.

Authors:  David B Shackelford; Evan Abt; Laurie Gerken; Debbie S Vasquez; Atsuko Seki; Mathias Leblanc; Liu Wei; Michael C Fishbein; Johannes Czernin; Paul S Mischel; Reuben J Shaw
Journal:  Cancer Cell       Date:  2013-01-24       Impact factor: 31.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.